{
  "trial_id": "NCT04789135",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "treatment of the diagnoses made and submitted to the application of intravesical medicinal",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "ozone gas",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Therapeutic Scheme",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "1\u00b0 Bladder wash with 0.9% Saline - 500 ml performed through urethral tube n\u00b0 10; 2\u00b0 Bladder emptying ; 3\u00b0 Medical Ozone gas infusion 20 \u00b5g / ml - 60ml, intravesical forecast of two weekly sessions, with a total of six applications.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Clinical Follow-up Patients will be evaluated at each session using the score IC/BPS and possible side effects. At the end of the sixth session, Uroculture and Urofluxometry will be scheduled.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Monthly assessments will be scheduled for up to six months from the end of treatment to verify the maintenance of therapeutic response over time DATA ANALYSIS Qualitative data will be grouped into categories followed by the corresponding percentage. The analysis will be performed using SPSS software and Microsoft Excel.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Quantitative data will be presented in frequency distribution tables with mean, median and descriptive statistics. Statistical analysis performed using Student's t-test with significance values p> 0.05.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "CLINICAL RISK It is a risk procedure estimated as small since the administration of Ozone with controlled doses is safe and determinant of small side effects. The discomfort caused by the use of the urethral tube is small and performed safely.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "The specialized professionals who will conduct the experiments will be available and able to offer any necessary attention BENEFIT Patients who will be included in the present study have chronic pathology with impaired quality of life and inadequate response to conventional therapy. Based on scientific evidence, Ozone Therapy is expected to be a treatment alternative.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Interstitial Cystitis",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Bladder pain Syndrome",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Malignant Neoplasm",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Bladder Lithiasis.",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Lower Tract Infections",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has a history of CVA, neurogenic bladder with indwelling suprapubic catheter and multiple prior admissions for UTIs. They present with urosepsis now resolved after treatment.",
  "_meta": {
    "topic_id": "13",
    "trial_id": "NCT04789135",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}